Japan’s Takeda to Invest $2Bln in Developing Medicine Against Alzheimer’s Disease

MOSCOW (Sputnik) - Japanese pharmaceutical company Takeda Pharmaceutical has entered into an agreement with Swiss drug developer AC Immune under which it will invest up to $2.2 billion to develop a cure for Alzheimer's disease, the Japanese company said.